NSEGeneral Updates15 Jul 2026 · 15 Jul 2026, 05:54 pm

General Updates

Medplus Health Services Limited · MEDPLUS

✦ AI Summary▼ NegativeRegulatory

MedPlus Health Services Limited has received three suspension orders for drug licenses of its subsidiary Optival Health Solutions Private Limited in the state of Karnataka, resulting in potential revenue loss of Rs 0.77 lacs, Rs 0.35 lacs, and Rs 0.47 lacs respectively.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment2/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

MEDPLUS_15072026175122_Intimation_Signed.pdf

pdf

Download →
View document text
MedPlus Health Services Limited July 15, 2026 The Listing Department The Listing Department BSE Limited N ational Stock Exchange of India Limited Phiroze Jeejebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Fort, Plot No. C/1, G Block, Mumbai – 400001 Bandra - Kurla Complex BSE Scrip Code: 543427 Bandra (East), Mumbai – 400051 NSE Symbol: MEDPLUS Dear Sir/Madam, Sub: Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 We would like to inform you that Optival Health Solutions Private Limited, a subsidiary of the company, has received three suspension orders for a Drug License of a store situated in the state of Karnataka: Pursuant to SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated January 30, 2026, the details of the matter are as follows: Name(s) of the Nature and details of the Date of receipt of Details of the Impact on financial Authority action(s) taken, initiated or direction or order, violation(s)/ operation or other order(s) passed including any interim contravention(s) activities of the or interim orders, or committed or listed entity, any other alleged to be quantifiable in communication from committed monetary terms to the authority the extent possible Suspension of Drug License Potential Revenue Assistant Director, for one day of store situated Loss of Rs 0.77 lacs. Drugs Control at Sarakki JP Nagar Metro Administration Station, Karnataka Under Rule 65 of Bangalore Circle-3, Suspension of Drug License Order received on Potential Revenue Drugs and Cosmetics Bangalore, Karnataka. for one day of store situated 14.07.2026 Loss of Rs 0.35 lacs. Act, 1940 and Drugs at Jaraganahalli, Karnataka and Cosmetics Rules, Assistant Director, Suspension of Drug License Potential Revenue 1945 Drugs Control for two days of store situated Loss of Rs 0.47 lacs. Administration, at K C Road Chikkodi, Belgaum Circle, Karnataka Belgaum, Karnataka. The same will be available on the website of the Company at www.medplusindia.com and also on the websites of BSE Limited and National Stock Exchange of India Ltd. viz. www.bseindia.com and www.nseindia.com respectively. Kindly take the same on records. For MedPlus Health Services Limited Gangadi Madhukar Reddy Managing Director and Chief Executive Officer DIN: 00098097 040-6724 672 Regd. off. H. No: 11-6-56, Survey No: 257 & 258/1, Opp: IDPL Railway Siding Road, Moosapet, Kukatpally, Hyderabad – 500037, Telangana, India CIN No: L85110TG2006PLC051845 I Website: www.medplusindia.com I Email:medplus@medplusindia.com